Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1904218rdf:typepubmed:Citationlld:pubmed
pubmed-article:1904218lifeskim:mentionsumls-concept:C0205102lld:lifeskim
pubmed-article:1904218lifeskim:mentionsumls-concept:C0005220lld:lifeskim
pubmed-article:1904218lifeskim:mentionsumls-concept:C0205245lld:lifeskim
pubmed-article:1904218lifeskim:mentionsumls-concept:C0332466lld:lifeskim
pubmed-article:1904218lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:1904218lifeskim:mentionsumls-concept:C0332256lld:lifeskim
pubmed-article:1904218lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:1904218lifeskim:mentionsumls-concept:C0138765lld:lifeskim
pubmed-article:1904218lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:1904218pubmed:issue1lld:pubmed
pubmed-article:1904218pubmed:dateCreated1991-7-5lld:pubmed
pubmed-article:1904218pubmed:abstractTextAlpha complementation of beta-galactosidase (beta gal) is intracistronic and requires interaction between the alpha donor region (residues 3-41) and alpha acceptor fragment (produced by M15). We have constructed two plasmids which direct the synthesis of hybrid beta gal: coxsackievirus proteins in Escherichia coli. One plasmid, pBD1045, encodes an enzymatically active 3C protease of coxsackievirus B3 fused between the amino-terminal 79 amino acids of beta gal (containing the alpha donor region) and amino acids 80 to 1023 (alpha acceptor region). A second plasmid, pBD1043 encodes an inactive 3C protease and results in a fusion of 260 coxsackievirus amino acids between residues 79 and 80 of the beta gal monomer. Both hybrid proteins expressed by these constructs have beta-galactosidase activity regardless of whether the viral protease (183 amino acids) is autocatalytically cleaved out of the chimeric protein (pBD1045) or remains as part of a fusion protein (pBD1043). The implications of these results for structural flexibility of the complemented beta-galactosidase enzyme are discussed.lld:pubmed
pubmed-article:1904218pubmed:languageenglld:pubmed
pubmed-article:1904218pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1904218pubmed:citationSubsetIMlld:pubmed
pubmed-article:1904218pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1904218pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1904218pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1904218pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1904218pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1904218pubmed:statusMEDLINElld:pubmed
pubmed-article:1904218pubmed:monthMaylld:pubmed
pubmed-article:1904218pubmed:issn0006-291Xlld:pubmed
pubmed-article:1904218pubmed:authorpubmed-author:DasmahapatraB...lld:pubmed
pubmed-article:1904218pubmed:authorpubmed-author:DwyerSSlld:pubmed
pubmed-article:1904218pubmed:authorpubmed-author:WindheuserM...lld:pubmed
pubmed-article:1904218pubmed:issnTypePrintlld:pubmed
pubmed-article:1904218pubmed:day31lld:pubmed
pubmed-article:1904218pubmed:volume177lld:pubmed
pubmed-article:1904218pubmed:ownerNLMlld:pubmed
pubmed-article:1904218pubmed:authorsCompleteYlld:pubmed
pubmed-article:1904218pubmed:pagination243-51lld:pubmed
pubmed-article:1904218pubmed:dateRevised2007-10-11lld:pubmed
pubmed-article:1904218pubmed:meshHeadingpubmed-meshheading:1904218-...lld:pubmed
pubmed-article:1904218pubmed:meshHeadingpubmed-meshheading:1904218-...lld:pubmed
pubmed-article:1904218pubmed:meshHeadingpubmed-meshheading:1904218-...lld:pubmed
pubmed-article:1904218pubmed:meshHeadingpubmed-meshheading:1904218-...lld:pubmed
pubmed-article:1904218pubmed:meshHeadingpubmed-meshheading:1904218-...lld:pubmed
pubmed-article:1904218pubmed:meshHeadingpubmed-meshheading:1904218-...lld:pubmed
pubmed-article:1904218pubmed:meshHeadingpubmed-meshheading:1904218-...lld:pubmed
pubmed-article:1904218pubmed:meshHeadingpubmed-meshheading:1904218-...lld:pubmed
pubmed-article:1904218pubmed:meshHeadingpubmed-meshheading:1904218-...lld:pubmed
pubmed-article:1904218pubmed:meshHeadingpubmed-meshheading:1904218-...lld:pubmed
pubmed-article:1904218pubmed:meshHeadingpubmed-meshheading:1904218-...lld:pubmed
pubmed-article:1904218pubmed:meshHeadingpubmed-meshheading:1904218-...lld:pubmed
pubmed-article:1904218pubmed:meshHeadingpubmed-meshheading:1904218-...lld:pubmed
pubmed-article:1904218pubmed:meshHeadingpubmed-meshheading:1904218-...lld:pubmed
pubmed-article:1904218pubmed:year1991lld:pubmed
pubmed-article:1904218pubmed:articleTitleExpression of functional beta-galactosidase containing the coxsackievirus 3C protease as an internal fusion.lld:pubmed
pubmed-article:1904218pubmed:affiliationSchering-Plough Research, Bloomfield, New Jersey 07003.lld:pubmed
pubmed-article:1904218pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1904218lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1904218lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1904218lld:pubmed